BBIO:NASDAQ
BridgeBio Pharma Inc
$72.50
arrow_downward
-4.71%(-3.58) 1D
$74.00
arrow_upward
+2.07% (+1.50)bedtimeAfter hours
Closed: Sep 10, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BBIO...
Open
$75.27
High
$75.50
Low
$72.12
Mkt. cap
14.17B
Avg. vol.
2.04M
Volume
0.00
52-wk high
$93.42
52-wk low
$48.78
EPS
-$3.57
Beta
0.97
Shares outstanding
195.49M
No. of employees
1K
Open
$75.27
High
$75.50
Low
$72.12
Mkt. cap
14.17B
Avg. vol.
2.04M
Volume
0.00
52-wk high
$93.42
52-wk low
$48.78
EPS
-$3.57
Beta
0.97
Shares outstanding
195.49M
No. of employees
1K
News stories
From web sources and news partners
Investing.com Canada
·
16 hours ago
BridgeBio at Cantor global healthcare conference: launch pipeline in focus By Investing.com
GuruFocus
·
17 hours ago
BBIO Reiterated by HC Wainwright & Co. -- Rating Maintained at B
Seeking Alpha
·
17 hours ago
BridgeBio Pharma: Attruby Peak Sales Set To Rise
Investing.com
·
18 hours ago
H.C. Wainwright reiterates BridgeBio Pharma stock rating at buy
About BridgeBio Pharma Inc
CEONeil Kumar
Employees1K
Founded2015
HeadquartersPalo Alto, California, United States
SectorBiotechnology
Websitebridgebio.com